BACKGROUND. To test the prognostic value of plasma renin activity prospectively, we determined the pretreatment renin-sodium profile of 1717 subjects with mild-to-moderate hypertension (mean age, 53 years; 36 percent white; 67 percent men) in a systematic work-site treatment program. METHODS. Renin profiles, obtained by plotting plasma renin activity against the urinary excretion of sodium, were classified as high (12 percent of the subjects), normal (56 percent), and low (32 percent), and there were expected variations according to age, sex, and race. Modified stepped-care treatment for hypertension, prescribed without reference to the renin profile, was similar in the three renin groups. RESULTS. Mean (+/- SD) blood pressure at entry was 151 +/- 19/100 +/- 10 mm Hg in the subjects with a high renin profile, 151 +/- 19/97 +/- 10 mm Hg in those with a normal profile, and 151 +/- 20/96 +/- 11 mm Hg in those with a low profile. During 8.3 years of follow-up, there were 27 myocardial infarctions. As adjusted for age, sex, and race, the incidence of myocardial infarction per 1000 person-years was 14.7 among the subjects with a high renin profile, 5.6 among those with a normal profile, and 2.8 among those with a low profile (rate ratio for high vs. low, 5.3; 95 percent confidence interval, 3.4 to 8.3). The rate of mortality from all causes was 9.3 in the high-profile group, 5.3 in the normal-profile group, and 3.9 in the low-profile group. The independent association of a high renin profile with myocardial infarction (but not with stroke or noncardiovascular events) was affirmed by Cox analyses (rate ratio for high vs. normal plus low, 3.2; 95 percent confidence interval, 1.2 to 8.4) after adjustment for race, sex, age at entry, serum cholesterol level, smoking status, electrocardiographic evidence of left ventricular hypertrophy, blood glucose level, body-mass index, history of cardiovascular disease or treatment, blood pressure, and use of beta-blockers. CONCLUSIONS. In the study population, whose blood pressure before and during treatment was in a narrow range, and after other cardiovascular risk factors had been considered, the renin profile before treatment remained independently associated with the subsequent risk of myocardial infarction.
Source Information
Department of Epidemiology and Social Medicine, Albert Einstein College of Medicine, Bronx, N.Y. 10461-1602.
This article has been cited by other articles:
Usalan, C., Buyukhatipoglu, H.
(2008). A Dynamic Comparative Study Concerning the Effects of Angiotensin-Converting Enzyme Inhibitors and Aldosterone Receptor Blockers on the Fibrinolytic System. CLIN APPL THROMB HEMOST
14: 203-209
[Abstract]
Vasan, R. S., Demissie, S., Kimura, M., Cupples, L. A., Rifai, N., White, C., Wang, T. J., Gardner, J. P., Cao, X., Benjamin, E. J., Levy, D., Aviv, A.
(2008). Association of Leukocyte Telomere Length With Circulating Biomarkers of the Renin-Angiotensin-Aldosterone System: The Framingham Heart Study. Circulation
117: 1138-1144
[Abstract][Full Text]
Agirbasli, M., Cincin, A., Baykan, O. A
(2008). Short-term effects of angiotensin receptor blockers on blood pressure control, and plasma inflammatory and fibrinolytic parameters in patients taking angiotensin-converting enzyme inhibitors. Journal of Renin-Angiotensin-Aldosterone System
9: 22-26
[Abstract]
Parikh, N. I., Gona, P., Larson, M. G., Wang, T. J., Newton-Cheh, C., Levy, D., Benjamin, E. J., Kannel, W. B., Vasan, R. S.
(2007). Plasma renin and risk of cardiovascular disease and mortality: the Framingham Heart Study. Eur Heart J
28: 2644-2652
[Abstract][Full Text]
Adiyaman, A., Staessen, J. A.
(2007). Renin turning full circle as cardiovascular risk factor. Eur Heart J
28: 2557-2558
[Full Text]
Mateo, T., Naim Abu Nabah, Y., Losada, M., Estelles, R., Company, C., Bedrina, B., Cerda-Nicolas, J. M., Poole, S., Jose, P. J., Cortijo, J., Morcillo, E. J., Sanz, M.-J.
(2007). A critical role for TNF{alpha} in the selective attachment of mononuclear leukocytes to angiotensin-II-stimulated arterioles. Blood
110: 1895-1902
[Abstract][Full Text]
Dickinson, B. D., Havas, S., for the Council on Science and Public Health, Amer,
(2007). Reducing the Population Burden of Cardiovascular Disease by Reducing Sodium Intake: A Report of the Council on Science and Public Health. Arch Intern Med
167: 1460-1468
[Abstract][Full Text]
Authors/Task Force Members:, , Mancia, G., De Backer, G., Dominiczak, A., Cifkova, R., Fagard, R., Germano, G., Grassi, G., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., Narkiewicz, K., Ruilope, L., Rynkiewicz, A., Schmieder, R. E., Struijker Boudier, H. A.J., Zanchetti, A., ESC Committee for Practice Guidelines (CPG):, , Vahanian, A., Camm, J., De Caterina, R., Dean, V., Dickstein, K., Filippatos, G., Funck-Brentano, C., Hellemans, I., Kristensen, S. D., McGregor, K., Sechtem, U., Silber, S., Tendera, M., Widimsky, P., Zamorano, J. L., ESH Scientific Council:, , Kjeldsen, S. E., Erdine, S., Narkiewicz, K., Kiowski, W., Agabiti-Rosei, E., Ambrosioni, E., Cifkova, R., Dominiczak, A., Fagard, R., Heagerty, A. M., Laurent, S., Lindholm, L. H., Mancia, G., Manolis, A., Nilsson, P. M., Redon, J., Schmieder, R. E., Struijker-Boudier, H. A.J., Viigimaa, M., Document Reviewers:, , Filippatos, G., Adamopoulos, S., Agabiti-Rosei, E., Ambrosioni, E., Bertomeu, V., Clement, D., Erdine, S., Farsang, C., Gaita, D., Kiowski, W., Lip, G., Mallion, J.-M., Manolis, A. J., Nilsson, P. M., O'Brien, E., Ponikowski, P., Redon, J., Ruschitzka, F., Tamargo, J., van Zwieten, P., Viigimaa, M., Waeber, B., Williams, B., Zamorano, J. L.
(2007). 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J
0: ehm236v1-75
[Full Text]
Newton-Cheh, C., Guo, C.-Y., Gona, P., Larson, M. G., Benjamin, E. J., Wang, T. J., Kathiresan, S., O'Donnell, C. J., Musone, S. L., Camargo, A. L., Drake, J. A., Levy, D., Hirschhorn, J. N., Vasan, R. S.
(2007). Clinical and Genetic Correlates of Aldosterone-to-Renin Ratio and Relations to Blood Pressure in a Community Sample. Hypertension
49: 846-856
[Abstract][Full Text]
O'Brien, E., Barton, J., Nussberger, J., Mulcahy, D., Jensen, C., Dicker, P., Stanton, A.
(2007). Aliskiren Reduces Blood Pressure and Suppresses Plasma Renin Activity in Combination With a Thiazide Diuretic, an Angiotensin-Converting Enzyme Inhibitor, or an Angiotensin Receptor Blocker. Hypertension
49: 276-284
[Abstract][Full Text]
Wang, T. J., Gona, P., Larson, M. G., Tofler, G. H., Levy, D., Newton-Cheh, C., Jacques, P. F., Rifai, N., Selhub, J., Robins, S. J., Benjamin, E. J., D'Agostino, R. B., Vasan, R. S.
(2006). Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death. NEJM
355: 2631-2639
[Abstract][Full Text]
Luther, J. M., Gainer, J. V., Murphey, L. J., Yu, C., Vaughan, D. E., Morrow, J. D., Brown, N. J.
(2006). Angiotensin II Induces Interleukin-6 in Humans Through a Mineralocorticoid Receptor-Dependent Mechanism. Hypertension
48: 1050-1057
[Abstract][Full Text]
Ritz, E.
(2006). Salt--friend or foe?. Nephrol Dial Transplant
21: 2052-2056
[Full Text]
Grobe, J. L., Mecca, A. P., Mao, H., Katovich, M. J.
(2006). Chronic angiotensin-(1-7) prevents cardiac fibrosis in DOCA-salt model of hypertension. Am. J. Physiol. Heart Circ. Physiol.
290: H2417-H2423
[Abstract][Full Text]
Alderman, M. H.
(2006). Evidence relating dietary sodium to cardiovascular disease.. J. Am. Coll. Nutr.
25: 256S-261S
[Abstract][Full Text]
Douillette, A., Bibeau-Poirier, A., Gravel, S.-P., Clement, J.-F., Chenard, V., Moreau, P., Servant, M. J.
(2006). The Proinflammatory Actions of Angiotensin II Are Dependent on p65 Phosphorylation by the I{kappa}B Kinase Complex. J. Biol. Chem.
281: 13275-13284
[Abstract][Full Text]
Nagata, K., Obata, K., Xu, J., Ichihara, S., Noda, A., Kimata, H., Kato, T., Izawa, H., Murohara, T., Yokota, M.
(2006). Mineralocorticoid Receptor Antagonism Attenuates Cardiac Hypertrophy and Failure in Low-Aldosterone Hypertensive Rats. Hypertension
47: 656-664
[Abstract][Full Text]
Danser, A.H. J., Deinum, J.
(2005). Renin, Prorenin and the Putative (Pro)renin Receptor. Hypertension
46: 1069-1076
[Full Text]
Duffy, S. J., Biegelsen, E. S., Eberhardt, R. T., Kahn, D. F., Kingwell, B. A., Vita, J. A.
(2005). Low-Renin Hypertension With Relative Aldosterone Excess Is Associated With Impaired NO-Mediated Vasodilation. Hypertension
46: 707-713
[Abstract][Full Text]
Estelles, R., Milian, L., Nabah, Y. N. A., Mateo, T., Cerda-Nicolas, M., Losada, M., Ivorra, M. D., Issekutz, A. C., Cortijo, J., Morcillo, E. J., Blazquez, M. A., Sanz, M.-J.
(2005). Effect of boldine, secoboldine, and boldine methine on angiotensin II-induced neurtrophil recruitment in vivo. J. Leukoc. Biol.
78: 696-704
[Abstract][Full Text]
Ma, J., Albornoz, F., Yu, C., Byrne, D. W., Vaughan, D. E., Brown, N. J.
(2005). Differing Effects of Mineralocorticoid Receptor-Dependent and -Independent Potassium-Sparing Diuretics on Fibrinolytic Balance. Hypertension
46: 313-320
[Abstract][Full Text]
Verdecchia, P., Reboldi, G., Angeli, F., Gattobigio, R., Bentivoglio, M., Thijs, L., Staessen, J. A., Porcellati, C.
(2005). Angiotensin-Converting Enzyme Inhibitors and Calcium Channel Blockers for Coronary Heart Disease and Stroke Prevention. Hypertension
46: 386-392
[Abstract][Full Text]
Richards, A. M., Frampton, C. M.
(2005). N-Terminal-Pro-B-Type Natriuretic Peptide: Universal Marker of Cardiovascular Risk?. Circulation
112: 9-11
[Full Text]
Campbell, D. J., Woodward, M., Chalmers, J. P., Colman, S. A., Jenkins, A. J., Kemp, B. E., Neal, B. C., Patel, A., MacMahon, S. W.
(2005). Prediction of Myocardial Infarction by N-Terminal-Pro-B-Type Natriuretic Peptide, C-Reactive Protein, and Renin in Subjects With Cerebrovascular Disease. Circulation
112: 110-116
[Abstract][Full Text]
Kim, M. P., Zhou, M., Wahl, L. M.
(2005). Angiotensin II increases human monocyte matrix metalloproteinase-1 through the AT2 receptor and prostaglandin E2: implications for atherosclerotic plaque rupture. J. Leukoc. Biol.
78: 195-201
[Abstract][Full Text]
Main, J.
(2005). Atherosclerotic renal artery stenosis, ACE inhibitors, and avoiding cardiovascular death. Heart
91: 548-552
[Full Text]
Morganti, A.
(2005). Should a Diuretic Always Be the First Choice in Patients with Essential Hypertension? The Case for No. J. Am. Soc. Nephrol.
16: S70-S73
[Abstract][Full Text]
Nabah, Y. N. A., Mateo, T., Estelles, R., Mata, M., Zagorski, J., Sarau, H., Cortijo, J., Morcillo, E. J., Jose, P. J., Sanz, M.-J.
(2004). Angiotensin II Induces Neutrophil Accumulation In Vivo Through Generation and Release of CXC Chemokines. Circulation
110: 3581-3586
[Abstract][Full Text]
Schieffer, B., Bunte, C., Witte, J., Hoeper, K., Boger, R. H., Schwedhelm, E., Drexler, H.
(2004). Comparative effects of AT1-antagonism and angiotensin-converting enzyme inhibition on markers of inflammation and platelet aggregation in patients with coronary artery disease. J Am Coll Cardiol
44: 362-368
[Abstract][Full Text]
Arenas, I. A., Xu, Y., Lopez-Jaramillo, P., Davidge, S. T.
(2004). Angiotensin II-induced MMP-2 release from endothelial cells is mediated by TNF-{alpha}. Am. J. Physiol. Cell Physiol.
286: C779-C784
[Abstract][Full Text]
Sierra, C., Ruilope, L. M
(2004). Review: Role of the selective aldosterone receptor blockers in arterial hypertension. Journal of Renin-Angiotensin-Aldosterone System
5: 23-25
[Abstract]
Samson, R. H.
(2004). Hypertension and the Vascular Patient. VASC ENDOVASCULAR SURG
38: 103-119
[Abstract]
Unger, T., Jun Li,
(2004). The role of the renin-angiotensin-aldosterone system in heart failure. Journal of Renin-Angiotensin-Aldosterone System
5: S7-S10
[Abstract]
Galinanes, M., Fowler, A. G
(2004). Role of clinical pathologies in myocardial injury following ischaemia and reperfusion. Cardiovasc Res
61: 512-521
[Abstract][Full Text]
Alderman, M. H.
(2004). Dietary Sodium and Cardiovascular Health in Hypertensive Patients: The Case against Universal Sodium Restriction. J. Am. Soc. Nephrol.
15: S47-50
[Abstract][Full Text]
Li, L., Chu, Y., Fink, G. D., Engelhardt, J. F., Heistad, D. D., Chen, A. F.
(2003). Endothelin-1 Stimulates Arterial VCAM-1 Expression Via NADPH Oxidase-Derived Superoxide in Mineralocorticoid Hypertension. Hypertension
42: 997-1003
[Abstract][Full Text]
Young, W. F. Jr.
(2003). Minireview: Primary Aldosteronism--Changing Concepts in Diagnosis and Treatment. Endocrinology
144: 2208-2213
[Abstract][Full Text]
Brown, N. J.
(2003). Eplerenone: Cardiovascular Protection. Circulation
107: 2512-2518
[Abstract][Full Text]
Drexler, H.
(2003). Introduction. Eur Heart J Suppl
5: A1-A2
Schieffer, B.
(2003). Interaction of interleukin-6 and angiotensin II in atherosclerosis: culprit for inflammation?. Eur Heart J Suppl
5: A25-A30
[Abstract]
Brasier, A. R., Recinos, A. III, Eledrisi, M. S.
(2002). Vascular Inflammation and the Renin-Angiotensin System. Arterioscler. Thromb. Vasc. Bio.
22: 1257-1266
[Abstract][Full Text]
Hilfiker, A., Hilfiker-Kleiner, D., Fuchs, M., Kaminski, K., Lichtenberg, A., Rothkotter, H.-J., Schieffer, B., Drexler, H.
(2002). Expression of CYR61, an Angiogenic Immediate Early Gene, in Arteriosclerosis and Its Regulation by Angiotensin II. Circulation
106: 254-260
[Abstract][Full Text]
Walsh, C. R., Larson, M. G., Leip, E. P., Vasan, R. S., Levy, D.
(2002). Serum Potassium and Risk of Cardiovascular Disease: The Framingham Heart Study. Arch Intern Med
162: 1007-1012
[Abstract][Full Text]
Sawathiparnich, P., Kumar, S., Vaughan, D. E., Brown, N. J.
(2002). Spironolactone Abolishes the Relationship between Aldosterone and Plasminogen Activator Inhibitor-1 in Humans. J. Clin. Endocrinol. Metab.
87: 448-452
[Abstract][Full Text]
Martinez, D. V., Rocha, R., Matsumura, M., Oestreicher, E., Ochoa-Maya, M., Roubsanthisuk, W., Williams, G. H., Adler, G. K.
(2002). Cardiac Damage Prevention by Eplerenone: Comparison With Low Sodium Diet or Potassium Loading. Hypertension
39: 614-618
[Abstract][Full Text]
Bloomgarden, Z. T.
(2001). The American Diabetes Association's 48th Annual Advanced Postgraduate Course. Diabetes Care
24: 1489-1495
[Full Text]
Khalil, M. E., Basher, A. W., Brown, E. J. Jr, Alhaddad, I. A.
(2001). A remarkable medical story: benefits of angiotensin-converting enzyme inhibitors in cardiac patients. J Am Coll Cardiol
37: 1757-1764
[Abstract][Full Text]
Brown, N. J., Murphey, L. J., Srikuma, N., Koschachuhanan, N., Williams, G. H., Vaughan, D. E.
(2001). Interactive Effect of PAI-1 4G/5G Genotype and Salt Intake on PAI-1 Antigen. Arterioscler. Thromb. Vasc. Bio.
21: 1071-1077
[Abstract][Full Text]
Cohen, H. W., Madhavan, S., Alderman, M. H.
(2001). History of Treatment for Depression: Risk Factor for Myocardial Infarction in Hypertensive Patients. Psychosom. Med.
63: 203-209
[Abstract][Full Text]
Papademetriou, V., Mammillot, P., Redman, R., Notargiacomo, A., Narayan, P., Lakshman, R.
(2001). Prevention of atherosclerosis by specific AT1-receptor blockade with candesartan cilexetil. Journal of Renin-Angiotensin-Aldosterone System
2: S77-S80
[Abstract]
Sironi, L., Calvio, A. M., Arnaboldi, L., Corsini, A., Parolari, A., de Gasparo, M., Tremoli, E., Mussoni, L.
(2001). Effect of Valsartan on Angiotensin II-Induced Plasminogen Activator Inhibitor-1 Biosynthesis in Arterial Smooth Muscle Cells. Hypertension
37: 961-966
[Abstract][Full Text]
Weiss, D., Kools, J. J., Taylor, W. R.
(2001). Angiotensin II-Induced Hypertension Accelerates the Development of Atherosclerosis in ApoE-Deficient Mice. Circulation
103: 448-454
[Abstract][Full Text]
Kobori, H., Hayashi, M., Saruta, T.
(2001). Thyroid Hormone Stimulates Renin Gene Expression Through the Thyroid Hormone Response Element. Hypertension
37: 99-104
[Abstract][Full Text]
Lottermoser, K., Hertfelder, H.-J., Wehling, M., Schiermeyer, B., Vetter, H., Dusing, R.
(2000). Effects of the mineralocorticoid fludrocortisone on fibrinolytic function in healthy subjects. Journal of Renin-Angiotensin-Aldosterone System
1: 357-360
[Abstract]
PRESCOTT, G., SILVERSIDES, D. W., CHIU, S. M. L., REUDELHUBER, T. L.
(2000). Contribution of circulating renin to local synthesis of angiotensin peptides in the heart. Physiol. Genomics
4: 67-73
[Abstract][Full Text]
Alderman, M. H.
(2000). Salt, Blood Pressure, and Human Health. Hypertension
36: 890-893
[Abstract][Full Text]
Piqueras, L., Kubes, P., Alvarez, A., O'Connor, E., Issekutz, A. C., Esplugues, J. V., Sanz, M.-J.
(2000). Angiotensin II Induces Leukocyte-Endothelial Cell Interactions In Vivo Via AT1 and AT2 Receptor-Mediated P-Selectin Upregulation. Circulation
102: 2118-2123
[Abstract][Full Text]
Rocha, R., Stier, C. T. Jr., Kifor, I., Ochoa-Maya, M. R., Rennke, H. G., Williams, G. H., Adler, G. K.
(2000). Aldosterone: A Mediator of Myocardial Necrosis and Renal Arteriopathy. Endocrinology
141: 3871-3878
[Abstract][Full Text]
Felmeden, D. C, Lip, G. Y.
(2000). The renin-angiotensin-aldosterone system and fibrinolysis. Journal of Renin-Angiotensin-Aldosterone System
1: 240-244
Labinjoh, C., Newby, D. E., Dawson, P., Johnston, N. R., Ludlam, C. A., Boon, N. A., Webb, D. J.
(2000). Fibrinolytic actions of intra-arterial angiotensin II and bradykinin in vivo in man. Cardiovasc Res
47: 707-714
[Abstract][Full Text]
Grossman, E., Messerli, F. H., Neutel, J. M.
(2000). Angiotensin II Receptor Blockers: Equal or Preferred Substitutes for ACE Inhibitors?. Arch Intern Med
160: 1905-1911
[Full Text]
Kohler, H. P., Grant, P. J.
(2000). Plasminogen-Activator Inhibitor Type 1 and Coronary Artery Disease. NEJM
342: 1792-1801
[Full Text]
Prasad, A., Tupas-Habib, T., Schenke, W. H., Mincemoyer, R., Panza, J. A., Waclawin, M. A., Ellahham, S., Quyyumi, A. A.
(2000). Acute and Chronic Angiotensin-1 Receptor Antagonism Reverses Endothelial Dysfunction in Atherosclerosis. Circulation
101: 2349-2354
[Abstract][Full Text]
Mann, J. F. E.
(2000). Should the results of the HOPE study affect nephrological practice?. Nephrol Dial Transplant
15: 453-454
[Full Text]
Schieffer, B., Schieffer, E., Hilfiker-Kleiner, D., Hilfiker, A., Kovanen, P. T., Kaartinen, M., Nussberger, J., Harringer, W., Drexler, H.
(2000). Expression of Angiotensin II and Interleukin 6 in Human Coronary Atherosclerotic Plaques : Potential Implications for Inflammation and Plaque Instability. Circulation
101: 1372-1378
[Abstract][Full Text]
Lang, D., Mosfer, S. I., Shakesby, A., Donaldson, F., Lewis, M. J.
(2000). Coronary Microvascular Endothelial Cell Redox State in Left Ventricular Hypertrophy : The Role of Angiotensin II. Circ. Res.
86: 463-469
[Abstract][Full Text]
Pueyo, M. E., Gonzalez, W., Nicoletti, A., Savoie, F., Arnal, J.-F., Michel, J.-B.
(2000). Angiotensin II Stimulates Endothelial Vascular Cell Adhesion Molecule-1 via Nuclear Factor-{kappa}B Activation Induced by Intracellular Oxidative Stress. Arterioscler. Thromb. Vasc. Bio.
20: 645-651
[Abstract][Full Text]
Brown, N. J., Kim, K.-S., Chen, Y.-Q., Blevins, L. S., Nadeau, J. H., Meranze, S. G., Vaughan, D. E.
(2000). Synergistic Effect of Adrenal Steroids and Angiotensin II on Plasminogen Activator Inhibitor-1 Production. J. Clin. Endocrinol. Metab.
85: 336-344
[Abstract][Full Text]
Bavry, A. A., Li, D., Zander, D. S., Phillips, M. I., Mehta, J. L.
(2000). Inhibition of Arterial Thrombogenesis by Quinapril but Not Losartan. J CARDIOVASC PHARMACOL THER
5: 121-127
[Abstract]
Westheim, A. S., Bostrom, P., Christensen, C. C., Parikka, H., Rykke, E. O., Toivonen, L.
(1999). Hemodynamic and neuroendocrine effects for candoxatril and frusemide in mild stable chronic heart failure. J Am Coll Cardiol
34: 1794-1801
[Abstract][Full Text]
Zhang, H., Schmeisser, A., Garlichs, C. D, Plotze, K., Damme, U., Mugge, A., Daniel, W. G
(1999). Angiotensin II-induced superoxide anion generation in human vascular endothelial cells: Role of membrane-bound NADH-/NADPH-oxidases. Cardiovasc Res
44: 215-222
[Abstract][Full Text]
Hilgers, K. F., Langenfeld, M. R. W., Schlaich, M., Veelken, R., Schmieder, R. E.
(1999). 1166 A/C Polymorphism of the Angiotensin II Type 1 Receptor Gene and the Response to Short-Term Infusion of Angiotensin II. Circulation
100: 1394-1399
[Abstract][Full Text]
Tummala, P. E., Chen, X.-L., Sundell, C. L., Laursen, J. B., Hammes, C. P., Alexander, R. W., Harrison, D. G., Medford, R. M.
(1999). Angiotensin II Induces Vascular Cell Adhesion Molecule-1 Expression In Rat Vasculature : A Potential Link Between the Renin-Angiotensin System and Atherosclerosis. Circulation
100: 1223-1229
[Abstract][Full Text]
Brown, N. J., Agirbasli, M., Vaughan, D. E.
(1999). Comparative Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Type 1 Receptor Antagonism on Plasma Fibrinolytic Balance in Humans. Hypertension
34: 285-290
[Abstract][Full Text]
Kranzhofer, R., Schmidt, J., Pfeiffer, C. A. H., Hagl, S., Libby, P., Kubler, W.
(1999). Angiotensin Induces Inflammatory Activation of Human Vascular Smooth Muscle Cells. Arterioscler. Thromb. Vasc. Bio.
19: 1623-1629
[Abstract][Full Text]
Dorffel, Y., Latsch, C., Stuhlmuller, B., Schreiber, S., Scholze, S., Burmester, G. R., Scholze, J.
(1999). Preactivated Peripheral Blood Monocytes in Patients With Essential Hypertension. Hypertension
34: 113-117
[Abstract][Full Text]
Lonn, E. M, Yusuf, S.
(1999). Evidence based cardiology: Emerging approaches in preventing cardiovascular disease. BMJ
318: 1337-1341
[Full Text]
Kita, T.
(1999). LOX-1, a Possible Clue to the Missing Link Between Hypertension and Atherogenesis. Circ. Res.
84: 1113-1115
[Full Text]
Davidson, N. C., Struthers, A. D.
(1999). Nitric Oxide Regulates Renin Release During Salt Depletion but Does Not Alter Angiotensin Responses in Normal Humans. J CARDIOVASC PHARMACOL THER
4: 9-14
[Abstract]
Sloan, R. P., Shapiro, P. A., Bagiella, E., Myers, M. M., Gorman, J. M.
(1999). Cardiac Autonomic Control Buffers Blood Pressure Variability Responses to Challenge: A Psychophysiologic Model of Coronary Artery Disease. Psychosom. Med.
61: 58-68
[Abstract][Full Text]
Brown, N. J., Agirbasli, M. A., Williams, G. H., Litchfield, W. R., Vaughan, D. E.
(1998). Effect of Activation and Inhibition of the Renin-Angiotensin System on Plasma PAI-1. Hypertension
32: 965-971
[Abstract][Full Text]
Chen, X.-L., Tummala, P. E., Olbrych, M. T., Alexander, R. W., Medford, R. M.
(1998). Angiotensin II Induces Monocyte Chemoattractant Protein-1 Gene Expression in Rat Vascular Smooth Muscle Cells. Circ. Res.
83: 952-959
[Abstract][Full Text]
Preston, R. A., Materson, B. J., Reda, D. J., Williams, D. W., Hamburger, R. J., Cushman, W. C., Anderson, R. J., for the Department of Veterans Affairs Cooperative,
(1998). Age-Race Subgroup Compared With Renin Profile as Predictors of Blood Pressure Response to Antihypertensive Therapy. JAMA
280: 1168-1172
[Abstract][Full Text]
Rizzoni, D., Muiesan, M. L., Porteri, E., Salvetti, M., Castellano, M., Bettoni, G., Tiberio, G., Giulini, S. M., Monteduro, C., Garavelli, G., Agabiti-Rosei, E.
(1998). Relations between cardiac and vascular structure in patients with primary and secondary hypertension. J Am Coll Cardiol
32: 985-992
[Abstract][Full Text]
Yang, B. C., Phillips, M. I., Zhang, Y. C., Kimura, B., Shen, L. P., Mehta, P., Mehta, J. L.
(1998). Critical Role of AT1 Receptor Expression After Ischemia/Reperfusion in Isolated Rat Hearts : Beneficial Effect of Antisense Oligodeoxynucleotides Directed at AT1 Receptor mRNA. Circ. Res.
83: 552-559
[Abstract][Full Text]
Kamide, K., Hori, M. T., Zhu, J.-H., Barrett, J. D., Eggena, P., Tuck, M. L.
(1998). Insulin-Mediated Growth in Aortic Smooth Muscle and the Vascular Renin-Angiotensin System. Hypertension
32: 482-487
[Abstract][Full Text]
Graudal, N. A., Galloe, A. M., Garred, P.
(1998). Effects of Sodium Restriction on Blood Pressure, Renin, Aldosterone, Catecholamines, Cholesterols, and Triglyceride: A Meta-analysis. JAMA
279: 1383-1391
[Abstract][Full Text]
Yang, B., Li, D., Phillips, M I., Mehta, P., Mehta, J. L
(1998). Myocardial angiotensin II receptor expression and ischemia-reperfusion injury. Vasc Med
3: 121-130
[Abstract]
Dimmeler, S., Rippmann, V., Weiland, U., Haendeler, J., Zeiher, A. M.
(1997). Angiotensin II Induces Apoptosis of Human Endothelial Cells : Protective Effect of Nitric Oxide. Circ. Res.
81: 970-976
[Abstract][Full Text]
Capers, Q. IV, Alexander, R. W., Lou, P., Hector De Leon, P., Wilcox, J. N., Ishizaka, N., Howard, A. B., Taylor, W. R.
(1997). Monocyte Chemoattractant Protein-1 Expression in Aortic Tissues of Hypertensive Rats. Hypertension
30: 1397-1402
[Abstract][Full Text]
Shannon, J., Jordan, J., Costa, F., Robertson, R. M., Biaggioni, I.
(1997). The Hypertension of Autonomic Failure and Its Treatment. Hypertension
30: 1062-1067
[Abstract][Full Text]
Katz, S. A., Opsahl, J. A., Lunzer, M. M., Forbis, L. M., Hirsch, A. T.
(1997). Effect of Bilateral Nephrectomy on Active Renin, Angiotensinogen, and Renin Glycoforms in Plasma and Myocardium. Hypertension
30: 259-266
[Abstract][Full Text]
Vaughan, D. E., Rouleau, J.-L., Ridker, P. M., Arnold, J. M. O., Menapace, F. J., Pfeffer, M. A.
(1997). Effects of Ramipril on Plasma Fibrinolytic Balance in Patients With Acute Anterior Myocardial Infarction. Circulation
96: 442-447
[Abstract][Full Text]
Derkx, F. H.M., Schalekamp, M. A.D.H., Sealey, J. E., Catanzaro, D., Laragh, J. H.
(1997). More on Renin • The authors of the editorial referred to above reply:. Clin. Chem.
43: 694-697
[Full Text]
Oskarsson, H. J., Heistad, D. D.
(1997). Oxidative Stress Produced by Angiotensin Too: Implications for Hypertension and Vascular Injury. Circulation
95: 557-559
[Full Text]
Laursen, J. B., Rajagopalan, S., Galis, Z., Tarpey, M., Freeman, B. A., Harrison, D. G.
(1997). Role of Superoxide in Angiotensin II–Induced but Not Catecholamine-Induced Hypertension. Circulation
95: 588-593
[Abstract][Full Text]
Schunkert, H., Danser, A.H. J., Hense, H.-W., Derkx, F. H.M., Kurzinger, S., Riegger, G. A.J.
(1997). Effects of Estrogen Replacement Therapy on the Renin-Angiotensin System in Postmenopausal Women. Circulation
95: 39-45
[Abstract][Full Text]
Previous
